Standardisation of operating procedures for the detection of minimal disease by QRT-PCR in children with neuroblastoma: Quality assurance on behalf of SIOPEN-R-NET

This publication has 29 references indexed in Scilit:

• Potential Application of ELAVL4 Real-Time Quantitative Reverse Transcription-PCR for Detection of Disseminated Neuroblastoma Cells
  Clinical Chemistry, 2006
• Standardization of the Immunocytochemical Detection of Neuroblastoma Cells in Bone Marrow
  Journal of Histochemistry & Cytochemistry, 2005
• Lacking immunocytological GD2 expression in neuroblastoma: Report of 3 cases
  Pediatric Blood & Cancer, 2005
• Detecting minimal residual disease in neuroblastoma patients-the present state of the art
  Cancer Letters, 2005
• The Doublecortin Gene, A New Molecular Marker to Detect Minimal Residual Disease in Neuroblastoma
  Diagnostic Molecular Pathology, 2005
• Detection of Neuroblastoma Cells in Bone Marrow and Peripheral Blood by Different Techniques
  Clinical Cancer Research, 2004
• Impact of pre‐analytical handling on bone marrow mRNA gene expression
  British Journal of Haematology, 2004
• Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2^−ΔΔC_T Method
  Methods, 2001
• Molecular detection of low-level disease in patients with cancer
  The Journal of Pathology, 2000
• Early clinical evaluation of neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA
  European Journal Of Cancer, 1995